Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-337324
Filing Date
2017-11-08
Accepted
2017-11-08 16:31:58
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d460592d10q.htm 10-Q 388416
2 EX-31.1 d460592dex311.htm EX-31.1 6306
3 EX-31.2 d460592dex312.htm EX-31.2 6350
4 EX-32 d460592dex32.htm EX-32 5045
  Complete submission text file 0001193125-17-337324.txt   2981155

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20170930.xml EX-101.INS 578197
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20170930.xsd EX-101.SCH 30021
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20170930_cal.xml EX-101.CAL 42220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20170930_def.xml EX-101.DEF 128281
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20170930_lab.xml EX-101.LAB 304373
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20170930_pre.xml EX-101.PRE 223161
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 171187029
SIC: 2834 Pharmaceutical Preparations